Russia 's Direct Investment Fund ( RDIF ) announced a deal on Tuesday with Nepal ’s Trinity Pharmaceuticals to supply 25 million doses of the Sputnik V coronavirus vaccine . 
The agreement will enable 90 % of Nepal ’s population to get access to the Russian vaccine , according to the RDIF . 
" We are excited to announce our cooperation with Russian Direct Investment Fund , " Kishor Adhikari , Director of Trinity Pharmaceuticals , said . 
Russia approved the controversial Sputnik V shot before it went to crucial Phase 3 trials , and its early approval was met with widespread concern worldwide . 
" Trinity is waiting for results of the final trial of Sputnik V , " Adhikari said . 
" As soon as the vaccine is approved by Government of Nepal we will make it available for the population of Nepal , " he added . 
